title: Pannexin 1 channels mediate the release of ATP into the lumen of the rat urinary bladder.
abstract: CONCLUSIONS
  ATP is released through pannexin channels into the lumen of the rat urinary bladder in response to distension or stimulation with bacterial endotoxins. Luminal ATP plays a physiological role in the control of micturition because intravesical perfusion of apyrase or the ecto-ATPase inhibitor ARL67156 altered reflex bladder activity in the anaesthetized rat. The release of ATP from the apical and basolateral surfaces of the urothelium appears to be mediated by separate mechanisms because intravesical administration of the pannexin channel antagonist Brilliant Blue FCF increased bladder capacity, whereas i.v. administration did not. Intravesical instillation of small interfering RNA-containing liposomes decreased pannexin 1 expression in the rat urothelium in vivo and increased bladder capacity. These data indicate a role for pannexin-mediated luminal ATP release in both the physiological and pathophysiological control of micturition and suggest that urothelial pannexin may be a viable target for the treatment of overactive bladder disorders.
  ATP is released from the bladder epithelium, also termed the urothelium, in response to mechanical or chemical stimuli. Although numerous studies have described the contribution of this release to the development of various bladder disorders, little information exists regarding the mechanisms of release. In the present study, we examined the role of pannexin channels in mechanically-induced ATP release from the urothelium. PCR confirmed the presence of pannexin 1 and 2 mRNA in rat urothelial tissue, whereas immunofluorescence experiments localized pannexin 1 to all three layers of the urothelium. During continuous bladder cystometry in anaesthetized rats, inhibition of pannexin 1 channels using carbenoxolone (CBX) or Brilliant Blue FCF (BB-FCF) (1-100 μm, intravesically), or by using intravesical small interfering RNA, increased the interval between voiding contractions. Intravenous administration of BB-FCF (1-100 μg kg(-1) ) did not alter bladder activity. CBX or BB-FCF (100 μm intravesically) also decreased basal ATP concentrations in the perfusate from non-distended bladders and inhibited increases in ATP concentrations in response to bladder distension (15 and 30 cmH2 O pressure). Intravesical perfusion of the ATP diphosphohydrolase apyrase (2 U ml(-1) ), or the ATPase inhibitor ARL67156 (10 μm) increased or decreased reflex bladder activity, respectively. Intravesical instillation of bacterial lipopolysaccharides (LPS) (Escherichia coli 055:B5, 100 μg ml(-1) ) increased ATP concentrations in the bladder perfusate, and also increased voiding frequency; these effects were suppressed by BB-FCF. These data indicate that pannexin channels contribute to distension- or LPS-evoked ATP release into the lumen of the bladder and that luminal release can modulate voiding function.
authors: Department of Anaesthesiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15261, USA; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15261, USA; Department of Anatomy and Cell Biology, University of Pennsylvania School of Dental Medicine, Philadelphia, PA, 19104, USA.
authors: Jonathan M
authors: JM
authors: Beckel
authors: Stephanie L
authors: SL
authors: Daugherty
authors: Pradeep
authors: P
authors: Tyagi
authors: Amanda S
authors: AS
authors: Wolf-Johnston
authors: Lori A
authors: LA
authors: Birder
authors: Claire H
authors: CH
authors: Mitchell
authors: William C
authors: WC
authors: de Groat
mesh_terms: D000255:Adenosine Triphosphate / Q000378:metabolism*; D000818:Animals; D002229:Carbenoxolone / Q000494:pharmacology; D017630:Connexins / Q000235:genetics / Q000378:metabolism*; D005260:Female; D008070:Lipopolysaccharides / Q000494:pharmacology; D009419:Nerve Tissue Proteins / Q000235:genetics / Q000378:metabolism*; D034741:RNA, Small Interfering; D051381:Rats; D020318:Rats, Long-Evans; D017207:Rats, Sprague-Dawley; D001743:Urinary Bladder / Q000187:drug effects / Q000378:metabolism*; D014554:Urination / Q000502:physiology*; D019459:Urothelium / Q000187:drug effects / Q000378:metabolism*
chemical_list: D017630:Connexins; D008070:Lipopolysaccharides; D009419:Nerve Tissue Proteins; D034741:RNA, Small Interfering; C479936:pannexin 1, rat; D000255:Adenosine Triphosphate; D002229:Carbenoxolone
references: J Biol Chem. 2014 Jun 6;289(23):16565-75
references: 24759099
references: J Physiol. 2012 May 15;590(10):2285-304
references: 22411013
references: Cell Res. 2012 Jun;22(6):1022-33
references: 22231629
references: Cardiovasc Res. 2012 Aug 1;95(3):269-80
references: 22678409
references: Am J Physiol Renal Physiol. 2012 Nov 15;303(10):F1454-9
references: 22952282
references: Nature. 2013 Mar 14;495(7440):223-6
references: 23467090
references: Physiol Rev. 2013 Apr;93(2):653-80
references: 23589830
references: J Gen Physiol. 2013 May;141(5):649-56
references: 23589583
references: PLoS One. 2013;8(5):e64696
references: 23741373
references: J Physiol. 1999 Nov 15;521 Pt 1:249-60
references: 10562349
references: Curr Biol. 2000 Jun 29;10(13):R473-4
references: 10898987
references: Nature. 2000 Oct 26;407(6807):1011-5
references: 11069181
references: Trends Pharmacol Sci. 2001 Apr;22(4):182-8
references: 11282418
references: J Neurosci. 2001 Aug 1;21(15):5670-7
references: 11466438
references: Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13396-401
references: 11606761
references: J Physiol. 2002 Jun 1;541(Pt 2):591-600
references: 12042363
references: J Urol. 2002 Sep;168(3):1230-4
references: 12187273
references: Nat Neurosci. 2002 Sep;5(9):856-60
references: 12161756
references: Am J Physiol Renal Physiol. 2003 Sep;285(3):F423-9
references: 12759226
references: Cell. 2004 Apr 2;117(1):1-3
references: 15066275
references: FEBS Lett. 2004 Aug 13;572(1-3):65-8
references: 15304325
references: Am J Physiol Renal Physiol. 2004 Nov;287(5):F1084-91
references: 15251862
references: Exp Cell Res. 1996 Jan 10;222(1):48-53
references: 8549672
references: J Clin Invest. 2005 Sep;115(9):2412-22
references: 16110327
references: Am J Physiol Cell Physiol. 2006 Jan;290(1):C27-34
references: 16107499
references: Urology. 2005 Dec;66(6):1332-7
references: 16360479
references: Physiology (Bethesda). 2006 Apr;21:103-14
references: 16565476
references: Proc Natl Acad Sci U S A. 2006 May 16;103(20):7655-9
references: 16682648
references: Am J Physiol Renal Physiol. 2006 Aug;291(2):F332-40
references: 16597611
references: EMBO J. 2006 Nov 1;25(21):5071-82
references: 17036048
references: Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6436-41
references: 17389364
references: PLoS Pathog. 2007 Apr;3(4):e60
references: 17465679
references: Neuroscience. 2007 Apr 25;146(1):9-16
references: 17379420
references: Br J Pharmacol. 2007 Aug;151(7):1033-40
references: 17558440
references: Kidney Int. 2007 Nov;72(9):1057-64
references: 17667988
references: Brain Res Bull. 2011 Nov 25;86(5-6):380-4
references: 21924327
references: J Neurophysiol. 2012 Mar;107(6):1586-97
references: 22170966
references: J Physiol. 2012 Mar 15;590(6):1465-80
references: 22250215
references: J Physiol. 1997 Dec 1;505 ( Pt 2):503-11
references: 9423189
references: Am J Physiol. 1999 Apr;276(4 Pt 1):C955-68
references: 10199828
references: J Physiol. 1999 Oct 15;520 Pt 2:539-50
references: 10523421
references: J Physiol. 2005 Feb 1;562(Pt 3):859-71
references: 15576455
references: Neurochem Int. 2005 Sep;47(4):291-7
references: 15970360
references: J Neurophysiol. 2008 Jan;99(1):49-59
references: 17959738
references: J Neurosci. 2008 Feb 20;28(8):1977-87
references: 18287514
references: Am J Physiol Renal Physiol. 2008 Apr;294(4):F821-9
references: 18216148
references: Am J Physiol Renal Physiol. 2008 May;294(5):F1146-56
references: 18322018
references: Sci Signal. 2008;1(39):ra6
references: 18827222
references: J Mol Neurosci. 2008 Nov;36(1-3):310-20
references: 18563302
references: Am J Physiol Cell Physiol. 2009 Feb;296(2):C250-5
references: 18945939
references: J Biol Chem. 2009 Aug 7;284(32):21257-64
references: 19531473
references: Biochem Biophys Res Commun. 2009 Oct 9;388(1):1-5
references: 19619506
references: Am J Respir Cell Mol Biol. 2009 Nov;41(5):525-34
references: 19213873
references: Auton Neurosci. 2010 Feb 16;153(1-2):33-40
references: 19666243
references: Infect Immun. 2010 Aug;78(8):3609-15
references: 20515921
references: Nature. 2010 Oct 14;467(7317):863-7
references: 20944749
references: Channels (Austin). 2011 May-Jun;5(3):193-7
references: 21532340
references: Sci Rep. 2013;3:2152
references: 23827947
references: J Urol. 2013 Aug;190(2):757-64
references: 23454160
references: Biochem Pharmacol. 2014 Jan 15;87(2):371-9
references: 24269631
references: Am J Physiol Renal Physiol. 2014 Feb 1;306(3):F286-98
references: 24285497
references: Biomed Res Int. 2014;2014:830374
references: 24829920
references: Glia. 2014 Sep;62(9):1486-501
references: 24839011